Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Assets
Current assets:
Cash and cash equivalents
Total cash and cash equivalents
Accounts receivable
Total accounts receivable
Inventories
Prepaid expenses and other
Asset held for sale (note 7)
Net investment in lease (note 6)
Total net investment in lease (note 6)
Derivative instruments - current (note 22(c))
Total derivative instruments - current (note 22(c))
Acquisition related assets (note 5(a))
Current assets - discontinued operations (note 23)
Total current assets
Property, plant and equipment (note 7)
Total property, plant and equipment (note 7)
Vessels under construction (note 8)
Right-of-use assets (note 9)
Net investment in lease (note 6)
Total net investment in lease (note 6)
Goodwill (note 10)
Total goodwill (note 10)
Deferred tax assets (note 17)
Derivative instruments (note 22(c))
Other assets (note 11)
Total other assets (note 11)
Long term assets - discontinued operations (note 23)
Total assets
Liabilities and shareholders' equity
Current liabilities:
Accounts payable and accrued liabilities (note 20)
Total accounts payable and accrued liabilities (note 20)
Deferred revenue
Total deferred revenue
Income tax payable
Long-term debt - current (note 12)
Total long-term debt - current (note 12)
Operating lease liabilities - current (note 13)
Total operating lease liabilities - current (note 13)
Finance lease liabilities - current (note 14)
Total finance lease liabilities - current (note 14)
Other financing arrangements - current (note 15)
Other liabilities - current (note 16)
Total other liabilities - current (note 16)
Current liabilities - discontinued operations (note 23)
Total current liabilities
Long-term debt (note 12)
Total long-term debt (note 12)
Operating lease liabilities (note 13)
Total operating lease liabilities (note 13)
Other financing arrangements (note 15)
Total other financing arrangements (note 15)
Derivative instruments (note 22(c))
Total derivative instruments (note 22(c))
Other liabilities (note 16)
Total other liabilities (note 16)
Long term liabilities - discontinued operations (note 23)
Liabilities
Total liabilities
Cumulative redeemable preferred shares, $0.01 par value; 12,000,000 issued and outstanding (2023 – 12,000,000) (note 18 (e))
Total cumulative redeemable preferred shares, $0.01 par value; 12,000,000 issued and outstanding (2023 – 12,000,000) (note 18 (e))
Shareholders’ equity:
Share capital (note 18):
Common shares; $0.01 par value; 400,000,000 shares authorized (2021 - 400,000,000); 281,565,472 shares issued and outstanding (2021 - 247,024,699); 727,351 shares held in treasury (2021 – 727,351)
Total common shares; $0.01 par value; 400,000,000 shares authorized (2021 - 400,000,000); 281,565,472 shares issued and outstanding (2021 - 247,024,699); 727,351 shares held in treasury (2021 – 727,351)
Preferred shares; $0.01 par value; 150,000,000 shares authorized (2023 – 150,000,000); 14,118,833 shares issued and outstanding (2023 – 14,118,833) Common shares; $0.01 par value; 400,000,000 shares authorized (2023 – 400,000,000); 204,328,277 shares issued and outstanding (2023 – 204,328,277)
Additional paid in capital
Total additional paid in capital
Retained earnings
Total retained earnings
Accumulated other comprehensive loss
Total accumulated other comprehensive loss
Shareholders' equity
Total shareholders' equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support